Stock ELOX ELOXX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 02:34:32 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.8058 USD +2.65% Intraday chart for Eloxx Pharmaceuticals, Inc. +0.60% -32.85%
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
Mar. 13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 421.7 294.4 159.8 60.91 3.943 2.66 2.66 -
Enterprise Value (EV) 1 421.7 294.4 159.8 60.91 3.943 2.66 2.66 2.66
P/E ratio -8.28 x -5.49 x -4.63 x -0.74 x -0 x -0.1 x -0.11 x -0.12 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA - - - - - - - -
EV / FCF - -7,466,700 x -5,673,807 x -1,735,863 x - - - -
FCF Yield - -0% -0% -0% - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 878 1,000 1,004 2,156 2,166 3,301 3,301 -
Reference price 2 480.4 294.4 159.2 28.25 1.820 0.8058 0.8058 0.8058
Announcement Date 3/8/19 3/6/20 3/12/21 3/30/22 3/31/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - - - - - - - -
EBITDA - - - - - - - -
EBIT -47.56 -50.56 -33.46 -66.02 -34.42 - - -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) -47.06 -50.87 -34.58 -66.73 -36.06 - - -
Net income -47.18 -50.87 -34.58 -66.73 -36.06 - - -
Net margin - - - - - - - -
EPS 2 -58.00 -53.60 -34.40 -38.00 -666.0 -7.910 -7.390 -6.650
Free Cash Flow - -39.43 -28.17 -35.09 - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/8/19 3/6/20 3/12/21 3/30/22 3/31/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - - - - - - - - - - -
EBITDA - - - - - - - - - - -
EBIT -35.73 -10.24 -11.63 -10.95 -10.3 -7.142 -6.028 -5.483 -4.14 -3.637 -
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) -36.06 -9.885 -12.09 -11.62 -10.62 -7.508 -6.319 -6.23 -4.341 -3.592 -
Net income -36.06 -9.885 -12.09 -11.62 -10.62 -7.508 -6.319 -6.23 -4.341 -3.592 -
Net margin - - - - - - - - - - -
EPS 2 -21.60 -4.400 -4.000 -5.200 -4.800 -3.600 -3.050 -2.880 -1.960 -1.310 -1.430
Dividend per Share - - - - - - - - - - -
Announcement Date 8/16/21 11/8/21 3/30/22 5/6/22 8/12/22 11/10/22 3/31/23 5/12/23 8/11/23 11/13/23 -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - -39.4 -28.2 -35.1 - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 0.24 0.04 - 0.09 - - - -
Capex / Sales - - - - - - - -
Announcement Date 3/8/19 3/6/20 3/12/21 3/30/22 3/31/23 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8058 USD
Average target price
30 USD
Spread / Average Target
+3,623.05%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ELOXX PHARMACEUTICALS, INC. Stock Eloxx Pharmaceuticals, Inc.
-32.85% 2.66M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. Financials Eloxx Pharmaceuticals, Inc.